论文部分内容阅读
目前,恶性胶质瘤标准的治疗方案为手术后替莫唑胺同步放疗联合辅助化疗,近年来抗血管生成药物也被用于胶质瘤的治疗,这些治疗方法在一定程度改善了病人预后;但是恶性胶质瘤仍会复发,恶性胶质瘤的治疗效果和病情进展需要正确评价,其中影像学检查是最直观的评价方法。目前临床上应用最广的影像学评价标准是Macdonald标准,随着假性进展和假性反应的发现,国外相应制定了新的RANO标准。本文就恶性胶质瘤治疗后的影像学评估进行综述。
At present, the standard treatment of glioblastoma is temozolomide combined with adjuvant chemotherapy after surgery. In recent years, anti-angiogenic drugs have also been used in the treatment of gliomas. These treatments have improved the patient's prognosis to a certain extent. However, Tumor will still relapse, the treatment of malignant glioma and the progress of the disease needs to be correctly evaluated, including imaging examination is the most intuitive method of evaluation. At present, Macronald standard is the most widely used imaging standard in clinic. With the discovery of false progress and false reaction, a new RANO standard has been developed abroad. This article reviews the imaging evaluation of malignant glioma after treatment.